Anti-Ro/SSA-associated corrected QT interval prolongation in adults: The role of antibody level and specificity

Arthritis Care and Research

Volumn 63, Issue 10, 2011, Pages 1463-1470

  Lazzerini, Pietro Enea ^a   Capecchi, Pier Leopoldo ^a   Acampa, Maurizio ^a   Morozzi, Gabriella ^a   Bellisai, Francesca ^a   Bacarelli, Maria Romana ^a   Dragoni, Saverio ^a   Fineschi, Irene ^a   Simpatico, Antonella ^a   Galeazzi, Mauro ^a   Laghi Pasini, Franco ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RO ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ELECTROCARDIOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; POPULATION; PREVALENCE; QT PROLONGATION; WESTERN BLOTTING;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; ARRHYTHMIAS, CARDIAC; AUTOIMMUNITY; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CROSS REACTIONS; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; ITALY; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION;

EID: 81255128070     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20540     Document Type: Article

References (22)

1. Lee LA. Transient autoimmunity related to maternal autoantibodies: neonatal lupus. Autoimmun Rev 2005;4:207-13.
2. Lazzerini PE, Capecchi PL, Laghi Pasini F. Arrhythmogenicity of anti-Ro/SSA antibodies: from the newborn to the adult? In: Tarkowicz IR, editor. Progress in cardiac arrhythmias research. New York: Nova Science Publishers; 2008. p. 81-108.
3. Franceschini F, Cavazzana I. Anti-Ro/SSA and anti-La/SSB antibodies. Autoimmunity 2005;38:55-63.
4. Lazzerini PE, Capecchi PL, Acampa M, Selvi E, Guideri F, Bisogno S, et al. Arrhythmogenic effects of anti-Ro/SSA anti- bodies on the adult heart: more than expected? Autoimmun Rev 2009;9:40-4.
5. Lazzerini PE, Capecchi PL, Guideri F, Acampa M, Selvi E, Bisogno S, et al. Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications. Basic Res Cardiol 2008;103:1-11.
6. Lazzerini PE, Acampa M, Guideri F, Capecchi PL, Campanella V, Morozzi G, et al. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. Arthritis Rheum 2004;50:1248-52.
7. Costedoat-Chalumeau N, Amoura Z, Hulot JS, Ghillani P, Lechat P, Funck-Brentano C. Corrected QT interval in anti- SSA-positive adults with connective tissue disease: comment on the article by Lazzerini et al [letter]. Arthritis Rheum 2005;52:676-7.
8. Bourre-Tessier J, Clarke AE, Huynh T, Bernatsky S, Joseph L, Belisle P, et al. Prolonged corrected QT interval in anti-Ro/ SSA-positive adults with systemic lupus erythematosus. Arthritis Care Res 2011;63:1031-7.
9. Lazzerini PE, Capecchi PL, Laghi Pasini F. Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses. Scand J Immunol 2010;72:213-22.
10. Lazzerini PE, Capecchi PL, Guideri F, Bellisai F, Selvi E, Acampa M, et al. Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease. Am J Cardiol 2007;100:1029-34.
11. Nakamura K, Katayama Y, Kusano KF, Haraoka K, Tani Y, Nagase S, et al. Anti-KCNH2 antibody-induced long QT syndrome: novel acquired form of long QT syndrome. J Am Coll Cardiol 2007;50:1808-9.
12. Jaeggi E, Laskin C, Hamilton R, Kingdom J, Silverman E. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus. J Am Coll Cardiol 2010;55:2778-84.
13. Damoiseaux J, Boesten K, Giesen J, Austen J, Tervaert JW. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Ann N Y Acad Sci 2005;1050:340-7.
14. Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV. The ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009;53:982-91.
15. Gordon PA, Rosenthal E, Khamashta MA, Hughes GR. Absence of conduction defects in the electrocardiograms of mothers with children with congenital complete heart block. J Rheumatol 2001;28:366-9.
16. Ricchiuti V, Briand JP, Meyer O, Isenberg DA, Pruijn G, Muller S. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera. Clin Exp Immunol 1994;95:397-407.
17. Dugar M, Cox S, Limaye V, Gordon TP, Roberts-Thomson PJ. Diagnostic utility of anti-Ro52 detection in systemic autoimmunity. Postgrad Med J 2010;86:79-82.
18. Karnabi E, Boutjdir M. Role of calcium channels in congenital heart block. Scand J Immunol 2010;72:226-34.
19. Catterall WA. Structure and function of voltage-gated ion channels. Annu Rev Biochem 1995;64:493-531.
20. Burbelo PD, Ching KH, Han BL, Bush ER, Reeves WH, Iadarola MJ. Extraordinary antigenicity of the human Ro52 autoantigen. Am J Transl Res 2010;2:145-55.
21. Hayashi N, Koshiba M, Nishimura K, Sugiyama D, Nakamura T, Morinobu S, et al. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol 2008;18:153-60.
22. Hervier B, Rimbert M, Colonna F, Hamidou MA, Audrain M. Clinical significance of anti-Ro/SSA-52 kDa antibodies: a retrospective monocentric study. Rheumatology (Oxford) 2009; 48:964-7.